Aptar Pharma acquires Pulmotree
ATR•Aptar Pharma acquired Pulmotree.
1. Acquisition
Aptar Pharma acquired Pulmotree.
Related News
Acumen Pharmaceuticals may offer up to $500 million of securities in SEC filing
ABOS•
HyOrc plans 150-tonne-per-day waste-to-methanol plant in Portugal for 2028
HYOR•
Piedmont Realty Trust releases third quarter 2026 results
PDM•
US, Canada working on deal to ease steel, auto tariffs, sources say
SPY•
Openworld provides preliminary third-quarter 2026 estimated results and appoints Gerard Hernandez CFO
OPNW•